Homepage

	Anna Hake Max-Planck-Institut für Informatik Statistical Learning in Computational Biology Campus E1 4 66123 Saarbrücken, Germany
	email:	Anna.Hake@mpi-inf.mpg.de
	phone:	+49 681 9325 3027
	fax:	+49 681 9325 3099
	room:	527 (Building E1 4)

Publications

• Hake A, Pfeifer N
  Prediction of HIV-1 sensitivity to broadly neutralizing antibodies shows a trend towards resistance over time
  PLOS Computational Biology 2017 13(10): e1005789
  
• Olga S. Voitenko; Andi Dhroso; Anna Feldmann; Dmitry Korkin; Olga V. Kalinina
  Patterns of amino acid conservation in human and animal immunodeficiency viruses
  Bioinformatics 2016 32 (17): i685-i692
  
• J. F. Scheid*, Joshua A. Horwitz*, Y. Bar-On, E. F. Kreider, C.-L. Lu, J. C. C. Lorenzi, A. Feldmann, M. Braunschweig, L. Nogueira, T. Oliveira, I. Shimeliovich, R. Patel, L. Burke, Y. Z. Cohen, S. Hadrigan, A. Settler, M. Witmer-Pack, A. P. West, Jr., B. Juelg, T. Keler, T. Hawthorne, B. Zingman, R. M. Gulick, N. Pfeifer, G. H. Learn, M. S. Seaman, P. J. Bjorkman, F. Klein, S. J. Schlesinger, B. D. Walker, B. H. Hahn, M. C. Nussenzweig, and M. Caskey
  HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
  Nature 2016, 535, pp 556–560
  *: equal contribution
• T. Schoofs*, F. Klein*, M. Braunschweig*, K. F. Kreider, A. Feldmann , L. Nogueira, T. Oliveira, J. C. C. Lorenzi, E. H. Parrish, G. H. Learn, A. P. West, P. J. Bjorkman, S. J. Schlesinger, M. S. Seaman, J. Czartoski, M. J. McElrath, N. Pfeifer, B. H. Hahn, M. Caskey, and M. C. Nussenzweig
  HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
  Science 2016, 352 (6288), pp 997-1001
  *: equal contribution
• Feldmann A, Pfeifer N.
  From predicting to analyzing HIV-1 resistance to broadly neutralizing antibodies
  PeerJ PrePrints 3:e1304v1, 2015
  

Conference talks

• A. Feldmann and N. Pfeifer
  From Predicting to Analyzing HIV-1 Resistance to Broadly Neutralizing Antibodies
  German Conference on Bioinformatics , Dortmund, Germany 2015

Poster Presentations

• A. Feldmann and N. Pfeifer
  Further evidence for a continuous drift of the HIV-1 species towards higher resistance to neutralizing antibodies - also in non-B subtypes
  HIV Vaccines ,Olympic Valley, California USA, 2016.
  
  
• A. Feldmann and N. Pfeifer
  Estimating and Visualizing HIV-1 Susceptibility to Broadly Neutralizing Antibodies
  Conference on Retroviruses and Opportunistic Infections, Seattle, USA, 2015.
  
  
• A. Feldmann and N. Pfeifer
  Predicting and understanding HIV-1 susceptibility to broadly neutralizing antibodies
  European Conference on Computational Biology, Strasbourg, France, 2014.